NEOGAP Therapeutics AB
Company

NEOGAP Therapeutics AB

Pharmaceutical Manufacturing Karolinska, Se 31 employees
Employees
31
Contacts
3
Emails
3

NEOGAP Therapeutics AB Overview

Headquarters
Karolinska, Se
Website
www.neogap.se
Industry
Pharmaceutical Manufacturing
Employees
31
Founded
2016
Funding
472.2K
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About NEOGAP Therapeutics AB

NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.

NEOGAP Therapeutics AB Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

NEOGAP Therapeutics AB Org Chart

Sample employees and titles
Name Title Contact
Erik Holmgren Affiliated to Karolinska Institutet
Email
Alejandro Fernandez Woodbridge I Love the Smell of Fresh Fastq
Email
Guro Gafvelin Chief Technology Officer at Neogap
Email
Birce Akpinar Senior Scientist at Neogap Therapeutics
View

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Senior / Lead 1 profile

Compare Similar Companies to NEOGAP Therapeutics AB